Optis
Device Vascular
PDI 05415067037558
General payments
$2,263,350
Research payments
$13,635
Through program year 2025, $2,263,350 in general payments and $13,635 in research payments were reported against Optis (Vascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $9,685 | 8 |
| 2024 | General | $909,195 | 3,427 |
| 2023 | General | $1,099,849 | 4,824 |
| 2023 | Research | $3,700 | 2 |
| 2022 | General | $254,306 | 2,592 |
| 2021 | Research | $250 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 44 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
10,843 general · 11 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.